Cargando…

Digital innovations for retinal care in diabetic retinopathy

AIM: The purpose of this review is to examine the applications of novel digital technology domains for the screening and management of patients with diabetic retinopathy (DR). METHODS: A PubMed engine search was performed, using the terms “Telemedicine”, “Digital health”, “Telehealth”, “Telescreenin...

Descripción completa

Detalles Bibliográficos
Autores principales: Vujosevic, Stela, Limoli, Celeste, Luzi, Livio, Nucci, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374293/
https://www.ncbi.nlm.nih.gov/pubmed/35962258
http://dx.doi.org/10.1007/s00592-022-01941-9
_version_ 1784767760571564032
author Vujosevic, Stela
Limoli, Celeste
Luzi, Livio
Nucci, Paolo
author_facet Vujosevic, Stela
Limoli, Celeste
Luzi, Livio
Nucci, Paolo
author_sort Vujosevic, Stela
collection PubMed
description AIM: The purpose of this review is to examine the applications of novel digital technology domains for the screening and management of patients with diabetic retinopathy (DR). METHODS: A PubMed engine search was performed, using the terms “Telemedicine”, “Digital health”, “Telehealth”, “Telescreening”, “Artificial intelligence”, “Deep learning”, “Smartphone”, “Triage”, “Screening”, “Home-based”, “Monitoring”, “Ophthalmology”, “Diabetes”, “Diabetic Retinopathy”, “Retinal imaging”. Full-text English language studies from January 1, 2010, to February 1, 2022, and reference lists were considered for the conceptual framework of this review. RESULTS: Diabetes mellitus and its eye complications, including DR, are particularly well suited to digital technologies, providing an ideal model for telehealth initiatives and real-world applications. The current development in the adoption of telemedicine, artificial intelligence and remote monitoring as an alternative to or in addition to traditional forms of care will be discussed. CONCLUSIONS: Advances in digital health have created an ecosystem ripe for telemedicine in the field of DR to thrive. Stakeholders and policymakers should adopt a participatory approach to ensure sustained implementation of these technologies after the COVID-19 pandemic. This article belongs to the Topical Collection "Diabetic Eye Disease", managed by Giuseppe Querques.
format Online
Article
Text
id pubmed-9374293
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Milan
record_format MEDLINE/PubMed
spelling pubmed-93742932022-08-12 Digital innovations for retinal care in diabetic retinopathy Vujosevic, Stela Limoli, Celeste Luzi, Livio Nucci, Paolo Acta Diabetol Review Article AIM: The purpose of this review is to examine the applications of novel digital technology domains for the screening and management of patients with diabetic retinopathy (DR). METHODS: A PubMed engine search was performed, using the terms “Telemedicine”, “Digital health”, “Telehealth”, “Telescreening”, “Artificial intelligence”, “Deep learning”, “Smartphone”, “Triage”, “Screening”, “Home-based”, “Monitoring”, “Ophthalmology”, “Diabetes”, “Diabetic Retinopathy”, “Retinal imaging”. Full-text English language studies from January 1, 2010, to February 1, 2022, and reference lists were considered for the conceptual framework of this review. RESULTS: Diabetes mellitus and its eye complications, including DR, are particularly well suited to digital technologies, providing an ideal model for telehealth initiatives and real-world applications. The current development in the adoption of telemedicine, artificial intelligence and remote monitoring as an alternative to or in addition to traditional forms of care will be discussed. CONCLUSIONS: Advances in digital health have created an ecosystem ripe for telemedicine in the field of DR to thrive. Stakeholders and policymakers should adopt a participatory approach to ensure sustained implementation of these technologies after the COVID-19 pandemic. This article belongs to the Topical Collection "Diabetic Eye Disease", managed by Giuseppe Querques. Springer Milan 2022-08-12 2022 /pmc/articles/PMC9374293/ /pubmed/35962258 http://dx.doi.org/10.1007/s00592-022-01941-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review Article
Vujosevic, Stela
Limoli, Celeste
Luzi, Livio
Nucci, Paolo
Digital innovations for retinal care in diabetic retinopathy
title Digital innovations for retinal care in diabetic retinopathy
title_full Digital innovations for retinal care in diabetic retinopathy
title_fullStr Digital innovations for retinal care in diabetic retinopathy
title_full_unstemmed Digital innovations for retinal care in diabetic retinopathy
title_short Digital innovations for retinal care in diabetic retinopathy
title_sort digital innovations for retinal care in diabetic retinopathy
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374293/
https://www.ncbi.nlm.nih.gov/pubmed/35962258
http://dx.doi.org/10.1007/s00592-022-01941-9
work_keys_str_mv AT vujosevicstela digitalinnovationsforretinalcareindiabeticretinopathy
AT limoliceleste digitalinnovationsforretinalcareindiabeticretinopathy
AT luzilivio digitalinnovationsforretinalcareindiabeticretinopathy
AT nuccipaolo digitalinnovationsforretinalcareindiabeticretinopathy